• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of targeted axillary dissection with sentinel node biopsy alone on nodal recurrence for patients who have node-positive breast cancer treated with neoadjuvant chemotherapy: a critical appraisal.

作者信息

Venkataraman Janhavi, Al-Shamari Artefaa, Mokbel Kefah

机构信息

The London Breast Institute, Princess Grace Hospital, London, UK.

Hamad Medical Corporation, Doha, Qatar.

出版信息

Gland Surg. 2025 Jun 30;14(6):1171-1173. doi: 10.21037/gs-2025-152. Epub 2025 Jun 26.

DOI:10.21037/gs-2025-152
PMID:40671765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12261349/
Abstract
摘要

相似文献

1
Comparison of targeted axillary dissection with sentinel node biopsy alone on nodal recurrence for patients who have node-positive breast cancer treated with neoadjuvant chemotherapy: a critical appraisal.新辅助化疗治疗的淋巴结阳性乳腺癌患者，靶向腋窝清扫与单纯前哨淋巴结活检在淋巴结复发方面的比较：一项批判性评估。
Gland Surg. 2025 Jun 30;14(6):1171-1173. doi: 10.21037/gs-2025-152. Epub 2025 Jun 26.
2
Comparison of Targeted Axillary Dissection with Sentinel Node Biopsy Alone on Nodal Recurrence for Patients who have Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.新辅助化疗治疗的淋巴结阳性乳腺癌患者中，靶向腋窝清扫与单纯前哨淋巴结活检在淋巴结复发方面的比较。
Ann Surg Oncol. 2025 Jul;32(7):4847-4854. doi: 10.1245/s10434-025-17197-w. Epub 2025 Mar 25.
3
Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.新辅助化疗后，针对淋巴结阳性乳腺癌患者的腋窝处理模式发生变化，更多地采用仅前哨淋巴结活检：一项针对土耳其外科医生的调查（MF17 - 01）结果
Langenbecks Arch Surg. 2025 Jun 16;410(1):196. doi: 10.1007/s00423-025-03767-9.
4
Different strategies in de-escalation of axillary surgery in node-positive breast cancer following neoadjuvant treatment: a systematic review and meta-analysis of long-term outcomes.新辅助治疗后腋窝淋巴结阳性乳腺癌腋窝手术降阶梯治疗的不同策略：长期结局的系统评价和荟萃分析
Breast Cancer. 2025 Apr 5. doi: 10.1007/s12282-025-01692-9.
5
Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review.单独使用前哨淋巴结活检术在浸润性乳腺癌行 upfront 手术的临床阳性淋巴结患者中的安全性和准确性：一项系统评价。
Curr Oncol. 2023 Mar 7;30(3):3102-3110. doi: 10.3390/curroncol30030235.
6
Axillary node interventions in breast cancer: a systematic review.腋窝淋巴结干预在乳腺癌中的应用：系统综述。
JAMA. 2013 Oct 2;310(13):1385-94. doi: 10.1001/jama.2013.277804.
7
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.临床淋巴结阳性乳腺癌患者接受新辅助化疗后切除阳性淋巴结：ISPY-2 临床试验对腋窝手术的影响。
Ann Surg Oncol. 2024 Oct;31(11):7249-7259. doi: 10.1245/s10434-024-15792-x. Epub 2024 Jul 12.
8
Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis.新辅助系统治疗后腋窝淋巴结阳性乳腺癌患者降阶梯手术的诊断准确性：系统评价和荟萃分析。
Cancer Med. 2022 Nov;11(22):4085-4103. doi: 10.1002/cam4.4769. Epub 2022 May 3.
9
Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy.新辅助化疗后临床腋窝淋巴结阴性乳腺癌患者腋窝淋巴结转移发生率：选择性省略前哨淋巴结活检的理论依据
Clin Breast Cancer. 2025 Aug;25(6):529-533. doi: 10.1016/j.clbc.2025.03.021. Epub 2025 Apr 3.
10
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.乳腺癌新辅助化疗后腋窝手术降阶梯治疗的肿瘤学结局：I-SPY2临床试验中1500余例患者的结果
Ann Surg Oncol. 2025 May;32(5):3278-3291. doi: 10.1245/s10434-025-16973-y. Epub 2025 Feb 13.

本文引用的文献

1
Comparison of Targeted Axillary Dissection with Sentinel Node Biopsy Alone on Nodal Recurrence for Patients who have Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.新辅助化疗治疗的淋巴结阳性乳腺癌患者中，靶向腋窝清扫与单纯前哨淋巴结活检在淋巴结复发方面的比较。
Ann Surg Oncol. 2025 Jul;32(7):4847-4854. doi: 10.1245/s10434-025-17197-w. Epub 2025 Mar 25.
2
Navigating axillary staging post-neoadjuvant systemic therapy: innovations, efficacy, and oncologic safety.新辅助全身治疗后腋窝分期的探索：创新、疗效及肿瘤学安全性
Gland Surg. 2024 Jun 30;13(6):1146-1149. doi: 10.21037/gs-24-125. Epub 2024 Jun 26.
3
Wire-Free Targeted Axillary Dissection: A Pooled Analysis of 1300+ Cases Post-Neoadjuvant Systemic Therapy in Node-Positive Early Breast Cancer.
无线靶向腋窝淋巴结清扫术：对1300余例新辅助全身治疗后的淋巴结阳性早期乳腺癌病例的汇总分析
Cancers (Basel). 2024 Jun 7;16(12):2172. doi: 10.3390/cancers16122172.
4
Ultrasound Imaging for Detecting Metastasis to Level II and III Axillary Lymph Nodes after Axillary Lymph Node Dissection for Invasive Breast Cancer.超声成像在检测浸润性乳腺癌腋窝淋巴结清扫术后 II 区和 III 区腋窝淋巴结转移中的应用。
J Ultrasound Med. 2019 Nov;38(11):2925-2934. doi: 10.1002/jum.14998. Epub 2019 Mar 25.
5
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.基于 21 基因表达检测的乳腺癌辅助化疗。
N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.